Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

HAVN Life Sciences Inc. HAVLF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score
37/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

HAVN Life Sciences Inc. (HAVLF) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 34/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 32.4% (+0 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Fail), Moat 32/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

HAVLF SharesGrow Score Overview

49/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 32/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — HAVLF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
HAVLF: -100%/yr revenue is, -24882.4%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
100/100
Balance sheet HAVLF: Debt-to-Equity (D/E) ratio N/A, Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
32/100
HAVLF: Gross margin is 32.4% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 32/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.00001-0.01
Volume22.11K
Avg Volume (30D)10.52K
Market Cap$2.57K
Beta (1Y)-0.31
Share Statistics
IPO Date2021-01-08
Employees6
CEOTim Moore
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA4196213058

Price Chart

Track all markets on TradingView
HAVLF
HAVN Life Sciences Inc. ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.01

People Also View

TRYPF
TRYPF
Tryp Therapeutics Inc.
$0.06
+32.24%
 AWKNF
AWKNF
Awakn Life Sciences Corp.
$0.07
+0.00%
 NMLSF
NMLSF
Nova Mentis Life Science Corp.
$0.06
+15.89%
 WSNAF
WSNAF
Wesana Health Holdings Inc.
$0.02
+0.00%
 JSPRW
JSPRW
Jasper Therapeutics, Inc.
$0.02
+0.48%
 SRZNW
SRZNW
Surrozen, Inc.
$0.02
+7.39%
 REVBW
REVBW
Revelation Biosciences, Inc.
$0.01
-7.53%
 PSYBF
PSYBF
PsyBio Therapeutics Corp.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message